MYCIO Wealth Partners’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-181
| Closed | – | – | 472 |
|
|
2019
Q4 | $0 | Buy |
+181
| New | +$139 | ﹤0.01% | 514 |
|
|
2016
Q4 | – | Sell |
-1,587
| Closed | – | – | 854 |
|
|
2016
Q3 | $0 | Hold |
1,587
| – | – | ﹤0.01% | 1228 |
|
|
2016
Q2 | $0 | Hold |
1,587
| – | – | ﹤0.01% | 1211 |
|
|
2016
Q1 | $0 | Hold |
1,587
| – | – | ﹤0.01% | 965 |
|
|
2015
Q4 | $0 | Hold |
1,587
| – | – | ﹤0.01% | 988 |
|
|
2015
Q3 | $0 | Hold |
1,587
| – | – | ﹤0.01% | 999 |
|
|
2015
Q2 | $1K | Hold |
1,587
| – | – | ﹤0.01% | 694 |
|
|
2015
Q1 | $1K | Hold |
1,587
| – | – | ﹤0.01% | 648 |
|
|
2014
Q4 | $1K | Hold |
1,587
| – | – | ﹤0.01% | 618 |
|
|
2014
Q3 | $1K | Hold |
1,587
| – | – | ﹤0.01% | 611 |
|
|
2014
Q2 | $1K | Hold |
1,587
| – | – | ﹤0.01% | 621 |
|
|
2014
Q1 | $0 | Hold |
1,587
| – | – | ﹤0.01% | 680 |
|
|
2013
Q4 | $1K | Hold |
1,587
| – | – | ﹤0.01% | 577 |
|
|
2013
Q3 | $3K | Hold |
1,587
| – | – | ﹤0.01% | 490 |
|
|
2013
Q2 | $3K | Buy |
+1,587
| New | +$2.79K | ﹤0.01% | 502 |
|
MYCIO Wealth Partners's GCVRZ Position: Q1 2020 in Review
MYCIO Wealth Partners sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 181 shares.
MYCIO Wealth Partners first reported a position in GCVRZ in Q2 2013 and held it in 15 quarters. The position peaked at $3K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- MYCIO Wealth Partners reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- MYCIO Wealth Partners sold 181 Sanofi Contingent Value Rights shares in Q1 2020.
- MYCIO Wealth Partners first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 15 quarters.
- MYCIO Wealth Partners's Sanofi Contingent Value Rights position peaked at $3K in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on MYCIO Wealth Partners's 13F filing for Q1 2020, filed 14 May 2020.